|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Regulus Therapeutics Inc. (RGLS)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-07-01 Sale |
2019-07-02 5:42 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
5,783 | $1.311 | $7,584 | 262,384 (Direct) |
View |
| 2019-07-01 Sale |
2019-07-02 5:42 pm |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP |
2,225 | $1.311 | $2,918 | 35,624 (Direct) |
View |
| 2019-07-01 Sale |
2019-07-02 5:41 pm |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
2,669 | $1.311 | $3,500 | 77,870 (Direct) |
View |
| 2019-05-14 Sale |
2019-05-16 5:25 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
39,352 | $1.219 | $47,966 | 307,519 (Direct) |
View |
| 2019-05-14 Sale |
2019-05-16 5:21 pm |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
10,000 | $1.409 | $14,089 | 90,539 (Direct) |
View |
| 2019-05-14 Sale |
2019-05-16 5:21 pm |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP |
6,950 | $1.41 | $9,796 | 66,259 (Direct) |
View |
| 2019-05-07 Purchase(A) |
2019-05-10 10:59 am |
Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:08 pm |
Regulus Therapeutics Inc. | RGLS | Walker Paul Edward Director |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:07 pm |
Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:07 pm |
Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:06 pm |
Regulus Therapeutics Inc. | RGLS | MOTT DAVID M 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:06 pm |
Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:05 pm |
Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:05 pm |
Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:05 pm |
Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:04 pm |
Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:04 pm |
Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:02 pm |
Regulus Therapeutics Inc. | RGLS | BARRIS PETER J 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:02 pm |
Regulus Therapeutics Inc. | RGLS | Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
1,136,704 | $1.08 | $1,227,640 | 3,703,704 (Direct) |
View |
| 2019-05-07 Purchase |
2019-05-08 5:15 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
33,194 | $1.08 | $35,850 | 64,542 (Direct) |
View |
| 2019-05-07 Purchase |
2019-05-08 5:15 pm |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
29,630 | $1.08 | $32,000 | 37,849 (Direct) |
View |
| 2019-05-07 Purchase |
2019-05-08 5:14 pm |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
92,889 | $1.08 | $100,320 | 154,223 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-08 5:13 pm |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
370,370 | $1.08 | $400,000 | 1,189,872 (Direct) |
View |
| 2019-04-01 Sale |
2019-04-03 4:31 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
5,842 | $0.981 | $5,731 | 31,348 (Direct) |
View |
| 2019-04-01 Sale |
2019-04-03 4:16 pm |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
3,253 | $0.9814 | $3,192 | 9,372 (Direct) |
View |
| 2019-04-01 Sale |
2019-04-03 4:15 pm |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP |
2,710 | $0.9812 | $2,659 | 6,287 (Direct) |
View |
| 2018-12-28 Purchase |
2019-01-02 4:12 pm |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
50,000 | $1.091 | $54,570 | 835,073 (Direct) |
View |
| 2018-12-26 Purchase |
2018-12-28 4:21 pm |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
116,401 | $0.9737 | $113,338 | 785,073 (Direct) |
View |
| 2018-11-15 Purchase |
2018-11-19 4:03 pm |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
500,000 | $1.361 | $680,550 | 668,672 (Direct) |
View |
| 2018-11-16 Purchase |
2018-11-19 4:01 pm |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
7,100 | $1.41 | $10,011 | 27,596 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-05-07 Option Award |
2019-05-21 4:46 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
370,370 | $1.08 | 1,189,872 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-21 4:46 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
370,370 | $0.125 | 1,189,872 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-21 4:45 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
92,889 | $1.08 | 154,223 (Indirect) |
View |
| 2019-05-07 Option Award |
2019-05-21 4:45 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
92,889 | $0.125 | 154,223 (Indirect) |
View |
| 2019-05-07 Option Award |
2019-05-21 4:44 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
29,630 | $1.08 | 37,849 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-21 4:44 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
29,630 | $0.125 | 37,849 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-21 4:42 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
33,194 | $1.08 | 64,542 (Direct) |
View |
| 2019-05-07 Option Award |
2019-05-21 4:42 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
33,194 | $0.125 | 64,542 (Direct) |
View |
| 2019-05-14 Option Award |
2019-05-16 5:57 pm |
2019-05-14 2029-02-04 |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
8,000 | $0.95 | 8,000 (Direct) |
View |
| 2019-05-14 Option Award |
2019-05-16 5:25 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
188,385 | $0 | 307,519 (Direct) |
View |
| 2019-05-14 Option Award |
2019-05-16 5:25 pm |
2019-05-14 2029-02-04 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
10,000 | $0.95 | 307,519 (Direct) |
View |
| 2019-05-14 Option Award |
2019-05-16 5:21 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
55,414 | $0 | 90,539 (Direct) |
View |
| 2019-05-14 Option Award |
2019-05-16 5:21 pm |
2019-05-14 2029-02-04 |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
8,000 | $0.95 | 90,539 (Direct) |
View |
| 2019-05-14 Option Award |
2019-05-16 5:21 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP |
38,512 | $0 | 66,259 (Direct) |
View |
| 2019-05-14 Option Award |
2019-05-16 5:21 pm |
2019-05-14 2029-02-04 |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP |
7,500 | $0.95 | 66,259 (Direct) |
View |
| 2019-05-07 Purchase |
2019-05-10 10:59 am |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-10 10:59 am |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:08 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Walker Paul Edward Director |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:08 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | Walker Paul Edward Director |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:07 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:07 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:07 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:07 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:06 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | MOTT DAVID M 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:06 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | MOTT DAVID M 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:06 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:06 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:05 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:05 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:05 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:05 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:05 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:05 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:04 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:04 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:04 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:04 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:02 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | BARRIS PETER J 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:02 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | BARRIS PETER J 10% Owner |
256,700 | $10.8 | 3,703,704 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:02 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
3,703,704 | $0.125 | 3,703,704 (Direct) |
View |
| 2019-05-07 Purchase |
2019-05-09 6:02 pm |
2019-05-07 N/A |
Regulus Therapeutics Inc. | RGLS | Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
256,700 | $10.8 | 3,703,704 (Direct) |
View |
| 2019-05-07 Purchase |
2019-05-08 5:15 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
33,194 | $0.125 | 64,542 (Direct) |
View |
| 2019-05-07 Purchase |
2019-05-08 5:15 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
29,630 | $0.125 | 37,849 (Direct) |
View |
| 2019-05-07 Purchase |
2019-05-08 5:14 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
92,889 | $0.125 | 154,223 (Indirect) |
View |
| 2019-05-07 Purchase |
2019-05-08 5:13 pm |
2019-05-07 2024-05-07 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
370,370 | $0.125 | 1,189,872 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-06 4:52 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | WRIGHT TIMOTHY MICHAEL Chief R & D Officer |
40,000 | $0.95 | 62,893 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-06 4:52 pm |
N/A 2029-02-04 |
Regulus Therapeutics Inc. | RGLS | WRIGHT TIMOTHY MICHAEL Chief R & D Officer |
40,000 | $0.95 | 62,893 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-06 4:51 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
65,000 | $0.95 | 84,148 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-06 4:51 pm |
N/A 2029-02-04 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO |
65,000 | $0.95 | 84,148 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-06 4:50 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
30,000 | $0.95 | 34,578 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-06 4:50 pm |
N/A 2029-02-04 |
Regulus Therapeutics Inc. | RGLS | Chevallard Daniel R. CFO |
30,000 | $0.95 | 34,578 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-06 4:49 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP |
25,000 | $0 | 27,747 (Direct) |
View |
| 2019-02-05 Option Award |
2019-02-06 4:49 pm |
N/A 2029-02-04 |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP |
25,000 | $0.95 | 27,747 (Direct) |
View |
| 2018-11-12 Option Award |
2018-11-21 5:29 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
20,910 | $0 | 168,672 (Direct) |
View |
| 2018-11-12 Disposition |
2018-11-21 5:29 pm |
N/A 2022-02-08 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
152 | $31.92 | 168,672 (Direct) |
View |
| 2018-11-12 Disposition |
2018-11-21 5:29 pm |
N/A 2023-06-09 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
1,458 | $111.8 | 168,672 (Direct) |
View |
| 2018-11-12 Disposition |
2018-11-21 5:29 pm |
N/A 2024-05-21 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
1,458 | $74.64 | 168,672 (Direct) |
View |
| 2018-11-12 Disposition |
2018-11-21 5:29 pm |
N/A 2025-06-08 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
1,458 | $120.2 | 168,672 (Direct) |
View |
| 2018-11-12 Disposition |
2018-11-21 5:29 pm |
N/A 2026-05-31 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
3,051 | $74.4 | 168,672 (Direct) |
View |
| 2018-11-12 Disposition |
2018-11-21 5:29 pm |
N/A 2027-05-30 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
2,500 | $17.4 | 168,672 (Direct) |
View |
| 2018-11-12 Disposition |
2018-11-21 5:29 pm |
N/A 2028-05-16 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
6,250 | $8.52 | 168,672 (Direct) |
View |
| 2018-11-12 Disposition |
2018-11-21 5:29 pm |
N/A 2028-05-31 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
4,583 | $8.76 | 168,672 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Mon, 15 Jul 2019 23:17:45 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |